By staff writer Armed Forces Press

January 5, 2023

Read this link first: Click om image)

A related second article: US Department of Defense has been running the “covid vaccine” fraud worldwide. 

“[Pfizer] did not defraud the government. We delivered the fraud that the government ordered.”  Sasha Latypova used these words to describe the basis on which Pfizer has requested the dismissal of a False Claims Act case brought against them for their covid “vaccines.”

The US Department of Defence ordered “demonstrations” from pharmaceutical companies using the same secretive framework they use to order weapons.  While telling us they were pharmaceutical products, for legal reasons they described them as emergency use authorised “countermeasures.”  No pharmaceutical regulation applies to countermeasures.

“They were claiming that they’re producing pharmaceutical products to the good manufacturing standards when they perfectly well knew, I assure you, they were all aware of this. They perfectly well knew that no pharmaceutical regulations apply to these things, countermeasures … They’re just lying to you that these are pharmaceuticals. They’re actually not,” Latypova explained.

The international conference ‘Pandemic Strategies: Lessons and Consequences’ held at the Stockholm Waterfront on 21-22 January 2023 gathered 15 leading doctors, researchers and lawyers from the US, Canada, UK, Germany, France, Belgium, Switzerland, Israel, Ukraine and Norway, along with 7 Swedes.

Presentations and panel discussions are being released in the order that they appeared on the program at a rate of 3 per day.

Alexandra “Sasha” Latypova was one of those who gave a presentation.  She holds an MBA degree and is a former Pharmaceutical R&D Executive. Latypova has spent approximately 25 years in the pharmaceutical industry and has owned and managed several contract research organisations – conducting clinical trials for over 60 pharmaceutical clients worldwide. She became concerned about the irregularities, cover-up and apparent fraud relating to the extremely high number of deaths and injuries associated with the covid injection rollout.

In her presentation, she explained that her initial investigation was to look into the so-called covid vaccines’ compliance with good manufacturing practices. It is the practice required to conform to quality guidelines recommended by regulatory agencies and applies to drugs, food and other mass-produced products that are consumed. It is to ensure, for example, that if you buy your favourite beer today and then you go to the to buy it again a week from now or a month from now, your experience is the same. The same goes for medicines like Aspirin that you buy in a pharmacy. You don’t expect a product to be a thousand times different a week from now versus today.

“As a highly regulated industry, pharmaceutical manufacturers are supposed to comply with [good manufacturing practice]. And this means that the product that they claim that they make, with the ingredients that they claim that they make, is supposed to be in every vial, every shot, every pill, over and over and over again, and they should be almost identical to each other,” Latypova said.

In the first few months of her investigation, Latypova found evidence of “very bad manufacturing practices” in relation to the mRNA injections. “When I looked at the [ ] graph [of serious adverse events and deaths recorded in VAERS] for mRNA injections for the US, I found [the below]”

Article continues at the link:

Also at this Stockholm conference, Dr. Robert Malone made an interesting and revealing presentation.  Presented in non-technical lay terms but fast moving.  Transcript and link to Dr. Malone’s slides and video of his presentation on my blog.

About budbromley

Bud is a retired life sciences executive. Bud's entrepreneurial leadership exceeded three decades. He was the senior business development, marketing and sales executive at four public corporations, each company a supplier of analytical and life sciences instrumentation, software, consumables and service. Prior to those positions, his 19 year career in Hewlett-Packard Company's Analytical Products Group included worldwide sales and marketing responsibility for Bioscience Products, Global Accounts and the International Olympic Committee, as well as international management assignments based in Japan and Latin America. Bud has visited and worked in more than 65 countries and lived and worked in 3 countries.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.